IsoRay, Inc.
(NYSE Amex Equities : ISR)

( )
ISR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
HZNPHorizon Therapeutics Plc -1.44%69.045.6%$170.86m
CTLTCatalent, Inc. -5.16%94.652.1%$113.40m
VRXValeant Pharmaceuticals International, Inc. -0.34%19.2514.1%$113.27m
BHCBausch Health Cos., Inc. -0.34%19.250.0%$83.35m
JAZZJazz Pharmaceuticals Plc -1.03%142.832.4%$78.28m
GWPHGW Pharmaceuticals Plc 3.10%129.336.1%$67.70m
UTHRUnited Therapeutics Corp. -1.70%135.4314.1%$63.17m
PRGOPerrigo Co. Plc 1.89%48.656.8%$55.66m
SAGESAGE Therapeutics, Inc. 2.45%79.888.6%$42.39m
ARGXargenx SE -2.50%262.280.0%$37.95m
ICLRICON plc -0.77%186.374.2%$37.35m
SAVACassava Sciences, Inc. 2.11%7.250.0%$34.20m
AMRNAmarin Corp. Plc 0.45%4.481.5%$32.90m
PCRXPacira Biosciences, Inc. 0.56%64.2810.0%$31.75m
CORTCorcept Therapeutics, Inc. -0.52%22.885.4%$31.63m

Company Profile

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The company focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.